Glutamine/Glutamate ratio
|
Basic information |
| Metabolite name | Glutamine/Glutamate ratio |
 | N/A |
 |
N/A |
 |
N/A |
| Synonyms | glutamine/glutamate; |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | Glutamine/Glutamate ratio |
| N/A |
|
N/A |
|
N/A |
| Synonyms | glutamine/glutamate; |
| No. of studies | 6 |
|
Relationship between Glutamine/Glutamate ratio and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M065 | Type2 | depressed group at 6-weeks treatment vs. baseline | Plasma | Human | Up |
| Study M084 | Type1 | melancholic depressed group vs. control group | Plasma | Human | Unknown |
| Study M1129 | Type1 | high dose of perfluorooctane sulfonate group vs. control group | Hippocampus | C57BL/6J mouse | Down |
| Study M1129 | Type1 | middle dose of perfluorooctane sulfonate group vs. control group | Hippocampus | C57BL/6J mouse | Down |
| Study M115 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M115 | Type2 | MDD treated group 8-week vs. baseline | Plasma | Human | Up |
| Study M342 | Type3 | ketamine group vs. placebo group at 24 h post-treatment | Pregenual anterior cingulate cortex | Human | Up |
| Study M342 | Type3 | ketamine group 24 h post-treatment vs. baseline | Pregenual anterior cingulate cortex | Human | Up |
| Study M535 | Type1 | MDD group vs. control group | Pregenual anterior cingulate cortex | Human | Up |